Advertisement Pre-clinical R&D Pipeline - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
close icon


Advanced Nanomedicine for Oncology, Dermatology and Neurology Indications

More info about ADVANCELL

Pre-clinical R&D Pipeline


ADVANCELL generates proprietary drug candidates by leveraging an innovative nanosystems drug delivery technology to reformulate and reposition existing drugs.

The company focuses on oncological and dermatological indications. Projects in these areas continue to reach the evaluation and feasibility stage.

In addition, other indications with significant market potential and considerable unmet medical need are also being evaluated due to the versatility of the nanosystem platform.

Quick Contact Pre-clinical R&D Pipeline